221 related articles for article (PubMed ID: 3443058)
21. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients.
Liedholm H; Melander A
J Cardiovasc Pharmacol; 1989 Jul; 14(1):109-13. PubMed ID: 2475701
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and haemodynamics of felodipine as monotherapy in hypertensive patients.
Edgar B; Collste P; Haglund K; Regårdh CG
Drugs; 1987; 34 Suppl 3():28-9. PubMed ID: 3443061
[No Abstract] [Full Text] [Related]
23. The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients.
McLay JS; MacDonald TM; Hosie J; Elliott HL;
Eur J Clin Pharmacol; 2000 Nov; 56(8):529-35. PubMed ID: 11151741
[TBL] [Abstract][Full Text] [Related]
24. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
Katzman PL; Hulthén UL; Hökfelt B
Acta Med Scand; 1988; 223(2):125-31. PubMed ID: 3279724
[TBL] [Abstract][Full Text] [Related]
25. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
26. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
Saltiel E; Ellrodt AG; Monk JP; Langley MS
Drugs; 1988 Oct; 36(4):387-428. PubMed ID: 3069435
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive effect of felodipine combined with beta-blockade. A comparison between 2 and 3 daily dosages.
Hansson BG; Lyngstam G; Lyngstam O; Rydén L; Thilén U
Drugs; 1985; 29 Suppl 2():131-6. PubMed ID: 2859185
[TBL] [Abstract][Full Text] [Related]
29. Renal effects of felodipine in hypertension.
Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A
Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065
[TBL] [Abstract][Full Text] [Related]
30. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
31. Felodipine compared to prazosin as additional therapy to a beta-blocking drug.
Chalmers J; Wing L; West M; Bune A; Johnston C; Jackson B; McGrath B; Mashford ML; Heath W; Westwood B
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S82-4. PubMed ID: 2455150
[TBL] [Abstract][Full Text] [Related]
32. Felodipine versus hydrochlorothiazide as an addition to a beta-blocker in the treatment of hypertension.
Borgmästars H; Forsén B; Tuomilehto J; Hellebø R; Walle PO; Nielsen HM; Nielsen E; Winkel O; Steiness E; Ibsen H
Drugs; 1987; 34 Suppl 3():136-8. PubMed ID: 2894972
[No Abstract] [Full Text] [Related]
33. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
Todd PA; Faulds D
Drugs; 1992 Aug; 44(2):251-77. PubMed ID: 1382018
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect and tolerability of felodipine extended release (ER) tablets in comparison with felodipine plain tablets (PT) and placebo in hypertensives on a diuretic. Canadian Study Group.
Carruthers SG; Vint-Reed C
Clin Invest Med; 1993 Oct; 16(5):386-94. PubMed ID: 8261692
[TBL] [Abstract][Full Text] [Related]
35. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
36. Felodipine in hypertension--a review.
Elmfeldt D; Hedner T; Westerling S
J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S154-60. PubMed ID: 2442509
[TBL] [Abstract][Full Text] [Related]
37. Control of hypertension in elderly patients with felodipine and metoprolol: a double-blind, placebo-controlled clinical trial.
Freeling P; Davis RH; Goves JR; Burton RH; Orme-Smith EA
Br J Clin Pharmacol; 1987 Oct; 24(4):459-64. PubMed ID: 3318897
[TBL] [Abstract][Full Text] [Related]
38. Felodipine compared to nifedipine as "third-line drug" in resistant hypertension.
Maclean D; Mitchell ET; Readman AS
Angiology; 1986 Nov; 37(11):840-5. PubMed ID: 3789464
[TBL] [Abstract][Full Text] [Related]
39. Clinical trial of extended-release felodipine in pediatric essential hypertension.
Trachtman H; Frank R; Mahan JD; Portman R; Restaino I; Matoo TK; Tou C; Klibaner M
Pediatr Nephrol; 2003 Jun; 18(6):548-53. PubMed ID: 12700955
[TBL] [Abstract][Full Text] [Related]
40. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
Antonicelli R; Omboni S; Giovanni DC; Ansuini R; Mori A; Gesuita R; Parati G; Paciaroni E
Drugs Aging; 2002; 19(7):541-51. PubMed ID: 12182690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
